Streetbeat News

Analyst Ratings

PDSB

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on PDS Biotechnology (NASDAQ:PDSB) and maintained a price target of $21.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 10:52 am

VERU

HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Veru (NASDAQ:VERU) and maintained a $2 price target.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 10:50 am

MOTS

HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Motus GI Hldgs (NASDAQ:MOTS) and maintained a price target of $2.5.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 10:49 am

ROIV

Goldman Sachs analyst Corinne Jenkins maintains a Buy rating on Roivant Sciences (NASDAQ:ROIV) and raises the price target from $14 to $16.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 10:48 am

PLRX

HC Wainwright & Co. analyst Ed Arce maintains a 'Buy' rating on Pliant Therapeutics (NASDAQ:PLRX) and raises the price target from $50 to $52.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 10:46 am

ICPT

HC Wainwright & Co. analyst Ed Arce has downgraded Intercept Pharma (NASDAQ:ICPT) from Buy to Neutral and set a price target of $19.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 10:44 am

AKBA

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on Akebia Therapeutics (NASDAQ:AKBA) and maintained a price target of $3.75.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 10:42 am

ARCT

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on Arcturus Therapeutics (NASDAQ:ARCT) and maintained a price target of $51.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 10:41 am

UBER

Needham analyst Bernie McTernan has reiterated a 'Buy' rating on Uber Technologies (NYSE:UBER) and maintained a price target of $60.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 10:38 am

VRNT

Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on Verint Systems (NASDAQ:VRNT) and maintained a $40 price target.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 10:37 am